STANLEY T CROOKE Insider Trading $ISIS IONIS PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STANLEY T CROOKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STANLEY T CROOKE. STANLEY T CROOKE is Chairman & CEO in IONIS PHARMACEUTICALS INC ($ISIS) and Chairman and CEO in IONIS PHARMACEUTICALS INC ($ISIS) and Chairman, President, CEO in IONIS PHARMACEUTICALS INC ($ISIS) and Exec Chairman of the Board in IONIS PHARMACEUTICALS INC ($ISIS) and Executive Chairman of Board in IONIS PHARMACEUTICALS INC ($ISIS).
STANLEY T CROOKE in IONIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of STANLEY T CROOKE: Exec Chairman of the Board, Executive Chairman of Board, Chairman & CEO, Chairman and CEO, Chairman, President, CEO
Holdings: 2,021 shares
Latest Transaction: Jan 28 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STANLEY T CROOKE in IONIS PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 63.74 | 28,333 | 1,805,812 | 2,021 | 30.4 K to 2 K (-93.34 %) |
| Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 61.68 | 40,000 | 2,467,000 | 494,391 | 534.4 K to 494.4 K (-7.49 %) |
| Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 61.65 | 21,042 | 1,297,239 | 534,391 | 555.4 K to 534.4 K (-3.79 %) |
| Jan 25 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 60.53 | 13,958 | 844,878 | 555,433 | 569.4 K to 555.4 K (-2.45 %) |
| Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 0.00 | 4,371 | 0 | 7,801 | |
| Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 0.00 | 47,257 | 0 | 87,885 | |
| Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Payment of Exercise | F | 61.28 | 1,434 | 87,876 | 3,111 | 4.5 K to 3.1 K (-31.55 %) |
| Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 0.00 | 4,371 | 0 | 4,545 | 174 to 4.5 K (+2,512.07 %) |
| Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Payment of Exercise | F | 61.28 | 18,924 | 1,159,663 | 30,354 | 49.3 K to 30.4 K (-38.40 %) |
| Jan 20 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 0.00 | 47,257 | 0 | 49,278 | 2 K to 49.3 K (+2,338.30 %) |
| Jan 06 2021 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | A | 56.78 | 12,000 | 681,360 | 12,000 | |
| Dec 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.50 | 1,407 | 71,054 | 174 | 1.6 K to 174 (-88.99 %) |
| Dec 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 49.78 | 39,000 | 1,941,225 | 600,391 | 639.4 K to 600.4 K (-6.10 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 12,990 | 517,911 | 0 | |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.05 | 12,990 | 650,150 | 2,021 | 15 K to 2 K (-86.54 %) |
| Nov 30 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 12,990 | 517,911 | 15,011 | 2 K to 15 K (+642.75 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 2,590 | 103,263 | 12,990 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 11,600 | 462,492 | 15,580 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Option Exercise | M | 39.87 | 500 | 19,935 | 0 | |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.83 | 2,590 | 131,650 | 2,021 | 4.6 K to 2 K (-56.17 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 2,590 | 103,263 | 4,611 | 2 K to 4.6 K (+128.15 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.11 | 11,600 | 581,276 | 2,021 | 13.6 K to 2 K (-85.16 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 11,600 | 462,492 | 13,621 | 2 K to 13.6 K (+573.97 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.00 | 500 | 25,000 | 1,581 | 2.1 K to 1.6 K (-24.03 %) |
| Nov 25 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Buy | M | 39.87 | 500 | 19,935 | 2,081 | 1.6 K to 2.1 K (+31.63 %) |
| Sep 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.41 | 50,000 | 2,520,460 | 650,391 | 700.4 K to 650.4 K (-7.14 %) |
| Sep 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 50.18 | 2,000 | 100,360 | 1,581 | 3.6 K to 1.6 K (-55.85 %) |
| Jun 26 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 60.11 | 9,914 | 595,907 | 2,021 | 11.9 K to 2 K (-83.07 %) |
| Jun 26 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 58.80 | 5,000 | 294,000 | 11,935 | 16.9 K to 11.9 K (-29.52 %) |
| Jun 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 58.33 | 10,000 | 583,250 | 16,935 | 26.9 K to 16.9 K (-37.13 %) |
| Jun 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 58.25 | 2,000 | 116,500 | 3,581 | 5.6 K to 3.6 K (-35.84 %) |
| Jun 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 57.90 | 15,000 | 868,521 | 26,935 | 41.9 K to 26.9 K (-35.77 %) |
| Mar 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 45.00 | 1,000 | 45,000 | 6,581 | 7.6 K to 6.6 K (-13.19 %) |
| Mar 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 46.00 | 5,000 | 230,000 | 56,545 | 61.5 K to 56.5 K (-8.12 %) |
| Mar 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 44.75 | 10,000 | 447,546 | 61,545 | 71.5 K to 61.5 K (-13.98 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 45.00 | 4,349 | 195,705 | 71,545 | 75.9 K to 71.5 K (-5.73 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 45.00 | 5,651 | 254,295 | 75,894 | 81.5 K to 75.9 K (-6.93 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 44.50 | 5,421 | 241,235 | 81,545 | 87 K to 81.5 K (-6.23 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 44.50 | 4,969 | 221,121 | 86,966 | 91.9 K to 87 K (-5.40 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | M | 0.00 | 3,317 | 0 | 6,627 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | M | 0.00 | 39,643 | 0 | 72,160 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 0.00 | 5,545 | 0 | 5,545 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 0.00 | 62,982 | 0 | 62,982 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Payment of Exercise | F | 62.06 | 1,268 | 78,692 | 7,581 | 8.8 K to 7.6 K (-14.33 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Buy | M | 0.00 | 3,317 | 0 | 8,849 | 5.5 K to 8.8 K (+59.96 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Payment of Exercise | F | 62.06 | 17,342 | 1,076,245 | 91,935 | 109.3 K to 91.9 K (-15.87 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Buy | M | 0.00 | 39,643 | 0 | 109,277 | 69.6 K to 109.3 K (+56.93 %) |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 60.89 | 12,477 | 759,725 | 12,477 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 60.89 | 141,709 | 8,628,661 | 141,709 | |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 10,000 | 398,700 | 27,180 | |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 2,000 | 79,740 | 500 | |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 10,000 | 398,700 | 37,180 | |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 72.15 | 10,000 | 721,500 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 10,000 | 398,700 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 71.00 | 2,000 | 142,000 | 5,532 | 7.5 K to 5.5 K (-26.55 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 2,000 | 79,740 | 7,532 | 5.5 K to 7.5 K (+36.15 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 71.00 | 10,000 | 710,000 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Aug 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 10,000 | 398,700 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Jul 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman & CEO | Option Exercise | M | 39.87 | 10,000 | 398,700 | 47,180 | |
| Jul 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman & CEO | Sell | S | 70.25 | 10,000 | 702,506 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Jul 22 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman & CEO | Buy | M | 39.87 | 10,000 | 398,700 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 700 | 27,909 | 2,500 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 300 | 3,246 | 0 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 13,320 | 531,068 | 57,180 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 6,680 | 98,129 | 0 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 1,000 | 10,820 | 300 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 6,680 | |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.75 | 700 | 59,325 | 5,532 | 6.2 K to 5.5 K (-11.23 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 700 | 27,909 | 6,232 | 5.5 K to 6.2 K (+12.65 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.75 | 300 | 25,425 | 5,532 | 5.8 K to 5.5 K (-5.14 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 300 | 3,246 | 5,832 | 5.5 K to 5.8 K (+5.42 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.56 | 13,320 | 1,126,370 | 69,634 | 83 K to 69.6 K (-16.06 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 13,320 | 531,068 | 82,954 | 69.6 K to 83 K (+19.13 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 84.75 | 6,680 | 566,130 | 69,634 | 76.3 K to 69.6 K (-8.75 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 6,680 | 98,129 | 76,314 | 69.6 K to 76.3 K (+9.59 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 85.25 | 1,000 | 85,250 | 5,532 | 6.5 K to 5.5 K (-15.31 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 1,000 | 10,820 | 6,532 | 5.5 K to 6.5 K (+18.08 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 85.25 | 10,000 | 852,500 | 69,634 | 79.6 K to 69.6 K (-12.56 %) |
| Apr 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 10,000 | 146,900 | 79,634 | 69.6 K to 79.6 K (+14.36 %) |
| Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 37,000 | 1,475,190 | 70,500 | |
| Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 39.87 | 40,000 | 1,594,800 | 107,500 | |
| Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 61.54 | 37,000 | 2,276,799 | 69,634 | 106.6 K to 69.6 K (-34.70 %) |
| Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 37,000 | 1,475,190 | 106,634 | 69.6 K to 106.6 K (+53.13 %) |
| Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 60.07 | 40,000 | 2,402,700 | 69,634 | 109.6 K to 69.6 K (-36.49 %) |
| Feb 27 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 39.87 | 40,000 | 1,594,800 | 109,634 | 69.6 K to 109.6 K (+57.44 %) |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 2,346 | 0 | 4,612 | |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 30,587 | 0 | 48,077 | |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 5,332 | 0 | 5,332 | |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 63,726 | 0 | 63,726 | |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Payment of Exercise | F | 58.26 | 942 | 54,881 | 5,532 | 6.5 K to 5.5 K (-14.55 %) |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 2,346 | 0 | 6,474 | 4.1 K to 6.5 K (+56.83 %) |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Payment of Exercise | F | 58.26 | 12,686 | 739,086 | 69,634 | 82.3 K to 69.6 K (-15.41 %) |
| Jan 17 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 30,587 | 0 | 82,320 | 51.7 K to 82.3 K (+59.12 %) |
| Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 53.77 | 12,000 | 645,240 | 12,000 | |
| Jan 03 2019 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 53.77 | 143,400 | 7,710,618 | 143,400 | |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 4,000 | 43,280 | 2,904 | |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 9,962 | 146,342 | 16,680 | |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.50 | 2,000 | 89,000 | 4,128 | 6.1 K to 4.1 K (-32.64 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 2,000 | 21,640 | 6,128 | 4.1 K to 6.1 K (+48.45 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.30 | 2,000 | 88,600 | 4,128 | 6.1 K to 4.1 K (-32.64 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 2,000 | 21,640 | 6,128 | 4.1 K to 6.1 K (+48.45 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.50 | 4,981 | 221,655 | 51,733 | 56.7 K to 51.7 K (-8.78 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 4,981 | 73,171 | 56,714 | 51.7 K to 56.7 K (+9.63 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 44.30 | 4,981 | 220,658 | 51,733 | 56.7 K to 51.7 K (-8.78 %) |
| Apr 19 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 4,981 | 73,171 | 56,714 | 51.7 K to 56.7 K (+9.63 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 1,722 | 0 | 3,047 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 0.00 | 29,612 | 0 | 43,515 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 3,911 | 0 | 3,911 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 0.00 | 35,149 | 0 | 35,149 | |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.76 | 656 | 33,955 | 4,128 | 4.8 K to 4.1 K (-13.71 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 1,722 | 0 | 4,784 | 3.1 K to 4.8 K (+56.24 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 51.76 | 15,893 | 822,622 | 51,733 | 67.6 K to 51.7 K (-23.50 %) |
| Jan 17 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 0.00 | 29,612 | 0 | 67,626 | 38 K to 67.6 K (+77.90 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 1,000 | 10,820 | 7,904 | |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 36,642 | |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.01 | 1,000 | 52,010 | 3,062 | 4.1 K to 3.1 K (-24.62 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 1,000 | 10,820 | 4,062 | 3.1 K to 4.1 K (+32.66 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.01 | 10,000 | 520,100 | 38,014 | 48 K to 38 K (-20.83 %) |
| Jan 10 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 10,000 | 146,900 | 48,014 | 38 K to 48 K (+26.31 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.82 | 1,096 | 11,859 | 8,904 | |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 904 | 6,554 | 0 | |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 20,000 | 293,800 | 46,642 | |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.02 | 1,096 | 54,822 | 3,062 | 4.2 K to 3.1 K (-26.36 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.82 | 1,096 | 11,859 | 4,158 | 3.1 K to 4.2 K (+35.79 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 49.71 | 904 | 44,938 | 3,062 | 4 K to 3.1 K (-22.79 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 904 | 6,554 | 3,966 | 3.1 K to 4 K (+29.52 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 50.02 | 20,000 | 1,000,400 | 38,014 | 58 K to 38 K (-34.47 %) |
| Jan 05 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 20,000 | 293,800 | 58,014 | 38 K to 58 K (+52.61 %) |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 49.25 | 17,603 | 866,948 | 17,603 | |
| Jan 02 2018 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | A | 49.25 | 158,175 | 7,790,119 | 158,175 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 904 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 66,642 | |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 59.46 | 1,500 | 89,190 | 3,062 | 4.6 K to 3.1 K (-32.88 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 1,500 | 10,875 | 4,562 | 3.1 K to 4.6 K (+48.99 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 59.46 | 15,000 | 891,900 | 38,014 | 53 K to 38 K (-28.29 %) |
| Oct 17 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 15,000 | 220,350 | 53,014 | 38 K to 53 K (+39.46 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,000 | 7,250 | 2,404 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 10,000 | 146,900 | 81,642 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 1,500 | 10,875 | 3,404 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 14.69 | 15,000 | 220,350 | 91,642 | |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.25 | 500 | 27,125 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.20 | 500 | 27,100 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 500 | 3,625 | 3,562 | 3.1 K to 3.6 K (+16.33 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.25 | 5,000 | 271,250 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 54.20 | 5,000 | 271,000 | 38,014 | 43 K to 38 K (-11.62 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 14.69 | 5,000 | 73,450 | 43,014 | 38 K to 43 K (+13.15 %) |
| Oct 04 2017 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 52.50 | 500 | 26,250 | 3,062 | 3.6 K to 3.1 K (-14.04 %) |